Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells

Increased expression of Hypoxia-inducible factor-1 alpha (HIF-1 alpha) in the tumor microenvironment, mainly due to tumor growth, plays a major role in the growth of cancer. Tumor cells induce the expression of cyclooxygenase 2 (COX2) and its product, prostaglandin E2 (PGE2), through overexpression of HIF-1 alpha. It has been shown that ligation of PGE2 with its receptor, EP4, robustly promotes cancer progression. HIF-1 alpha/COX2/PGE2/EP4 signaling pathways appear to play an important role in tumor growth. Therefore, we decided to block the expansion of cancer cells by blocking the initiator (HIF-1 alpha) and end (EP4) of this pathway. In this study, we used hyaluronate (HA), and trimethyl chitosan (TMC) recoated superparamagnetic iron oxide nanoparticles (SPIONs) loaded with HIF-1 alpha-silencing siRNA and the EP4 antagonist (E7046) to treat cancer cells and assessed the effect of combination therapy on cancer progression. The results showed that optimum physicochemical characteristics of NPs (size 126.9 nm, zeta potential 27 mV, PDI < 0.2) and linkage of HA with CD44 molecules overexpressed on cancer cells could deliver siRNAs to cancer cells and significantly suppress the HIF-1a in them. Combination therapy of cancer cells by using HIF-1 alpha siRNA-loaded SPION-TMC-HA NPs and E7046 also prevent proliferation, migration, invasion, angiogenesis, and colony formation of the cancer cells, remarkably. (C) 2020 Published by Elsevier B.V.

Automated summary

Increased expression of HIF-1 alpha in the tumor microenvironment plays a major role in cancer growth by regulating COX2/PGE2/EP4 signaling pathways. Using specific nanoparticles for HIF-1 alpha silencing siRNA and EP4 antagonist treatment can effectively inhibit cancer cell growth and spread.